Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 Charts To Watch: ARQL, HROW, PYX, WKHS, XNCR

Published 06/26/2019, 01:41 AM
Updated 07/09/2023, 06:31 AM

It was another really bad day on Wall Street on Tuesday, but the technicals weren’t as bad as the price looked. I don’t know what that means yet, but we’ll see. A lot of the stocks we follow may, or are, swinging. In the meantime, let’s take a look at a few we highlighted here along with the charts.

ArQule, Inc. (ARQL)

ARQL is in a beautiful uptrend. It had the breakaway move a week and a half ago, and now it’s in a beautiful rising channel or flag. On Tuesday, it was up 81 cents or 8%, to 10.82, on nearly 13 million shares. That’s a significant increase in volume. If it could get through resistance, it could blow. It’s at the highest level in 17 years. The next target has to be up around 11 1/2, and 13. Keep your eye on this one going forward.

Harrow Health, Inc. (HROW)

HROW has been up for nine days in a row. On Tuesday, it popped 35 cents, or 4.62%, to 7.92, on 652,442 shares traded. The volume is excellent and it did break out. I’m still looking for more upside to 9-9 1/2-10 before it pulls back. At least that appears to be what is happening.

Pyxus International, Inc. (PYX)

PYX has a new swing I put on it on Tuesday. It had a nice pop of 3.61, or 27%, to 17.04, on 3.4 million shares. That’s huge volume for a stock that averages 638,681. I’m looking for a test around 20 1/2-21. If it gets through that, I’m looking at targets at 23 1/2, and then 26.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Workhorse Group Inc. (WKHS)

WKHS is looking well. It had a large ascending wedge after an explosive move in May and has a flag that really looks juicy. It popped out of the wedge to gain 21 cents, or 8%, to 2.85, on 3.7 million shares. I think this stock is going to make a run at 3-3 3/4. If it gets through that, 3-3 3/4, and then 5, are our targets.

Xencor, Inc. (XNCR)

XNCR has spent about nine months consolidating in a declining channel. It popped out and retested, forming a base, and then had a breakaway gap on Tuesday of 4.69, or 14%, to 38.56, on 1.9 million shares. That is massive volume for this stock. It tells me it needs to break out and run. The next target is 43, and then, ultimately, a retest of the high at 48 is my target.

Stocks on the long side included ArQule, Inc. (ARQL), Dova Pharmaceuticals, Inc. (DOVA), e.l.f. Beauty, Inc. (ELF), Harrow Health, Inc. (HROW), Hydrogenics Corporation (HYGS), MeiraGTx Holdings (MGTX), Melinta Therapeutics, Inc. (MLNT), Natera, Inc. (NTRA), Pyxus International, Inc. (PYX), Riot Blockchain, Inc. (RIOT), Workhorse Group Inc. (WKHS), and Xencor, Inc. (XNCR).

Watch Video Here

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.